Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while iShares 20 Plus Year Treasury Bond ETF trades at $79.64 (market cap $48.65B). The key difference: iShares 20 Plus Year Treasury Bond ETF is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares 20 Plus Year Treasury Bond ETF pays none. Which is the better fit depends on your goals.
| GEHC | TLT | |
|---|---|---|
Market Cap | $31.07B | $48.65B |
Volume | 3,443,020 | 29,149,160 |
Sector | Health | Fixed Income |
52-Week High | $88.16 | $92.06 |
52-Week Low | $59.48 | $77.11 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 83 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
TLT, the iShares 20+ Year Treasury Bond ETF, trades at $78.89, up 1.08% on the day but remains in a prolonged downtrend, having fallen 46% over five years. Technical indicators are bearish overall, with moving averages and oscillators signaling selling pressure. The fund continues to face headwinds from rising Treasury yields, which recently hit multi-decade highs, though recent PCE data provided some relief.
The outlook for TLT hinges on the direction of long-term interest rates. While current yields near 5.3% offer attractive income, further rate increases could pressure prices lower. Key risks include persistent inflation and Fed policy uncertainty. Investors should weigh high yield against potential capital depreciation in a rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
